ANIP FY 2008 Earnings — ANI Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

ANIPANI Pharmaceuticals, Inc.

$2B

FY 2008 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$4M+666.8% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$18M-476.4% margin

Net Income

-$17M-460.9% margin

EPS (Diluted)

$-22.97

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$16M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$18M

Total Liabilities

$4M

Stockholders' Equity

$14M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$493,054	+666.8%
Gross Profit	$4M	$493,054	+666.8%
Operating Income	-$18M	-$9M	-107.5%
Net Income	-$17M	-$8M	-129.7%